Please make JavaScript on and see this site.
Click here for detail
March 16, 2026
Points to Consider in the Clinical Development of Radiopharmaceuticals for Positron Emission Tomography Targeting Prostate Specific Membrane Antigen (PSMA PET) (Early Consideration) posted
Please note that this site may not be accurate due to machine translation, and all files (PDF, Excel, Word, PowerPoint) are not translated.